0001401914-24-000002.txt : 20240129
0001401914-24-000002.hdr.sgml : 20240129
20240129161834
ACCESSION NUMBER: 0001401914-24-000002
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240126
FILED AS OF DATE: 20240129
DATE AS OF CHANGE: 20240129
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Haring-Layton MarDee
CENTRAL INDEX KEY: 0001535596
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36395
FILM NUMBER: 24573903
MAIL ADDRESS:
STREET 1: 16870 WEST BERNARDO DRIVE
STREET 2: SUITE 120
CITY: SAN DIEGO
STATE: CA
ZIP: 92127
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dare Bioscience, Inc.
CENTRAL INDEX KEY: 0001401914
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 204139823
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3655 NOBEL DRIVE
STREET 2: SUITE 260
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
BUSINESS PHONE: 858-926-7655
MAIL ADDRESS:
STREET 1: 3655 NOBEL DRIVE
STREET 2: SUITE 260
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
FORMER COMPANY:
FORMER CONFORMED NAME: Cerulean Pharma Inc.
DATE OF NAME CHANGE: 20090714
FORMER COMPANY:
FORMER CONFORMED NAME: Tempo Pharmaceuticals Inc
DATE OF NAME CHANGE: 20070604
3
1
wk-form3_1706563099.xml
FORM 3
X0206
3
2024-01-26
0
0001401914
Dare Bioscience, Inc.
DARE
0001535596
Haring-Layton MarDee
C/O DARE BIOSCIENCE, INC.
3655 NOBEL DRIVE, SUITE 260
SAN DIEGO
CA
92122
0
1
0
0
Chief Accounting Officer
Employee Stock Option (right to buy)
2.37
2028-01-16
Common stock
3500
D
Employee Stock Option (right to buy)
1.01
2028-09-07
Common stock
30000
D
Employee Stock Option (right to buy)
0.759
2029-01-29
Common stock
35000
D
Employee Stock Option (right to buy)
1.03
2030-03-06
Common stock
25000
D
Employee Stock Option (right to buy)
2.59
2031-01-26
Common stock
52000
D
Employee Stock Option (right to buy)
1.59
2032-01-26
Common stock
42000
D
Employee Stock Option (right to buy)
1.16
2033-01-24
Common stock
80000
D
This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer.
/s/ MarDee Haring-Layton
2024-01-29